The effect of probiotics on immune cells in patients with pneumonia

Not Applicable

Completed

Conditions: Diseases of th respiratory system

Registration Number: KCT0005411

Lead Sponsor: The Forces Medical Command

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Male

Target Recruitment: 80

Inclusion Criteria

The diagnosis of pneumonia was based on the ATS/IDSA
guidelines for community-acquired pneumonia. Patient admitted for more than 48
hours, with no alternative foci of infection identified, plus at least, two of
the following criteria - Fever (38?) - Leukocytosis (>12,000/µl) or
leukopenia (<4,000/µl) - Purulent respiratory secretions - Rale (or crackle)
on physical examination - Abnormal blood gas analysis result Plus, new
infiltrates on chest x-ray

Exclusion Criteria

- HIV infection, syphylis, diabetes, hypertension, steroid
user - Persons with other serious accompanying diseases when judged by the
researcher.

Study & Design

Study Type: Interventional Study

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
clinical symptoms (fever, chills, cough, coryza, sputum, diarrhea, <br>constipation), fever subsidence, WBC, Hb, PLT, PT, CRP, AST, ALT, bilirubin, <br>albumin, creatinine, Bristol stool scale;clinical symptoms (fever, chills, cough, coryza, sputum, diarrhea, <br>constipation), fever subsidence, WBC, Hb, PLT, PT, CRP, AST, ALT, bilirubin, <br>albumin, creatinine, Bristol stool scale

Secondary Outcome Measures